These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6403982)

  • 21. [Carcinoembryonic antigen (CEA) levels and their clinical significance in Crohn's disease].
    Meryn S; Lochs H; Francesconi M
    Wien Klin Wochenschr; 1983 Apr; 95(9):301-4. PubMed ID: 6604368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
    Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease.
    Yang L; Ge ZZ; Gao YJ; Li XB; Dai J; Zhang Y; Xue HB; Zhao YJ
    J Gastroenterol Hepatol; 2013 May; 28(5):829-33. PubMed ID: 23425203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
    Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically active Crohn's disease in the presence of a low C-reactive protein.
    Florin TH; Paterson EW; Fowler EV; Radford-Smith GL
    Scand J Gastroenterol; 2006 Mar; 41(3):306-11. PubMed ID: 16497618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising monitoring in the management of Crohn's disease: a physician's perspective.
    Papay P; Ignjatovic A; Karmiris K; Amarante H; Milheller P; Feagan B; D'Haens G; Marteau P; Reinisch W; Sturm A; Steinwurz F; Egan L; Panés J; Louis E; Colombel JF; Panaccione R
    J Crohns Colitis; 2013 Sep; 7(8):653-69. PubMed ID: 23562672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
    Louis E; Ancion G; Colard A; Spote V; Belaiche J; Hustinx R
    J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.
    Jürgens M; Mahachie John JM; Cleynen I; Schnitzler F; Fidder H; van Moerkercke W; Ballet V; Noman M; Hoffman I; van Assche G; Rutgeerts PJ; van Steen K; Vermeire S
    Clin Gastroenterol Hepatol; 2011 May; 9(5):421-7.e1. PubMed ID: 21334460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease.
    Thalmaier D; Dambacher J; Seiderer J; Konrad A; Schachinger V; Pfennig S; Otte JM; Crispin A; Göke B; Ochsenkühn T; Lohse P; Brand S
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1105-15. PubMed ID: 16984505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study.
    Boirivant M; Leoni M; Tariciotti D; Fais S; Squarcia O; Pallone F
    J Clin Gastroenterol; 1988 Aug; 10(4):401-5. PubMed ID: 3418087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mean platelet volume (MPV) in Crohn's disease patients].
    Douda T; Bures J; Rejchrt S; Kopácová M; Pecka M; Malý J
    Cas Lek Cesk; 2006; 145(11):870-3. PubMed ID: 17168422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total parenteral nutrition modifies the acute phase response to Crohn's disease.
    Carlson GL; Gray P; Barber D; Shaffer JL; Mughal M; Irving MH
    J R Coll Surg Edinb; 1994 Dec; 39(6):360-4. PubMed ID: 7532715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intestinal resection on quality of life in Crohn's disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
    J Crohns Colitis; 2015 Jun; 9(6):452-62. PubMed ID: 25855073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.
    Tang J; Gao X; Zhi M; Zhou HM; Zhang M; Chen HW; Yang QF; Liang ZZ
    J Dig Dis; 2015 Mar; 16(3):118-24. PubMed ID: 25565427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
    Laharie D; Mesli S; El Hajbi F; Chabrun E; Chanteloup E; Capdepont M; Razaire S; de Lédinghen V; Zerbib F
    Aliment Pharmacol Ther; 2011 Aug; 34(4):462-9. PubMed ID: 21671970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
    Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose ascites mean more severe Crohn's disease?
    Lee JU; Kim YH; Lee SY; Kim KH; Chung CH; Kim KH; Son HJ; Rhee PL; Kim JJ; Rhee JC
    Korean J Gastroenterol; 2004 May; 43(5):304-9. PubMed ID: 15156117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.